✨ Health Regulations and Notices




Health

Human Assisted Reproductive Technology Act 2004

Guidelines Issued to the Ethics Committee on Assisted Reproductive Technology

The Advisory Committee on Assisted Reproductive Technology (ACART) has updated the following guidelines issued to the Ethics Committee on Assisted Reproductive Technology (ECART) on 22 November 2007 and published in the New Zealand Gazette, 29 November 2007, No. 130, page 3375, and New Zealand Gazette, 13 November 2008, No. 175, page 4522.

  • Guidelines on Donation of Eggs or Sperm between Certain Family Members.

    The preamble of the guidelines has been updated in line with amendments to the Human Assisted Reproductive Technology Order in Council that came into effect on 10 July 2009.

Pursuant to sections 36(2) and (4) of the Human Assisted Reproductive Technology Act 2004, copies of the guidelines are available from the Advisory Committee on Assisted Reproductive Technology (ACART), PO Box 5013, Wellington 6145. Telephone: (04) 816 2666. Email: acart@moh.govt.nz

The guidelines are also available online at www.acart.health.govt.nz

Dated at Palmerston North this 13th day of August 2009.

SYLVIA RUMBALL, Chair, Advisory Committee on Assisted Reproductive Technology.


Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Vexol
Active Ingredient: Rimexolone 10mg/mL
Dosage Form: Eye drops, suspension
New Zealand Sponsor: Alcon New Zealand Limited
Manufacturers: SA Alcon Couvreur NV, Puurs, Belgium
Alcon Cusi SA, El Masnou, Barcelona, Spain

Product: Volibris
Active Ingredient: Ambrisentan 10mg
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: Patheon Inc, Toronto Region Operations, Mississauga, Ontario, Canada

Product: Volibris
Active Ingredient: Ambrisentan 5mg
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: Patheon Inc, Toronto Region Operations, Mississauga, Ontario, Canada

Product: Xarelto
Active Ingredient: Rivaroxaban 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturer: Bayer Healthcare AG, Bayerwerk, Germany

Dated this 11th day of August 2009.

MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2009, No 119





✨ LLM interpretation of page content

πŸ₯ Guidelines Issued to the Ethics Committee on Assisted Reproductive Technology

πŸ₯ Health & Social Welfare
13 August 2009
Assisted Reproductive Technology, Guidelines, Ethics Committee, ACART
  • SYLVIA RUMBALL, Chair, Advisory Committee on Assisted Reproductive Technology

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
11 August 2009
Medicines, Distribution, Vexol, Volibris, Xarelto
  • MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health